Orally administered peptides to ameliorate atherosclerosis
CA 2718348 C · Owner: The Uab Research Foundation · Inventors: Navab, Mohamad; Anantharmaiah, Gattadahalli M.; Fogelman, Alan M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides novel peptides that ameliorate one or more symptoms of atherosclerosis (see Figure 23). The peptides comprises at least one class A amphipathic helix and at least one D-amino acid. The peptides are highly stable and readily administered via an oral route.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 23, 2001 and granted July 17, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 23, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 23, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.